跳至主要内容
临床试验/JPRN-jRCTa060190036
JPRN-jRCTa060190036已完成1 期

Adoptive immunotherapy using donor liver graft derived natural killer (NK) cells for preventing severe infection after liver transplantation

Ohdan Hideki0 个研究点目标入组 19 人开始时间: 2020年2月27日最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
19

研究概览

简要总结

Although 37 patients were planned to be enrolled in the study, 6 (31.5%) patients developed bacteremia at the time of 19 cases, and the study was terminated because it was difficult to achieve the primary endpoint. The failure to meet the primary endpoint may have been due to the large number of patients with immunological high-risk backgrounds, acute rejection, and the treatment of such patients.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) decompensated liver cirrhotic patients who will receive liver transplantation
  • 2) 20 years old or older
  • 3) written informed consent from patients or legal guardian

排除标准

  • 1) patients who will receive re-transplantation
  • 2) patients who will receive deceased donor liver transplantation
  • 3) patients whom the researchers decided as inappropriate to be participated

研究者

发起方
Ohdan Hideki

相似试验